Effectiveness of a Physical Therapy Telerehabilitation Program in Long Post COVID-19 Symptoms in Primary Health Care. (TPhysioCovid)
COVID-19, Physical Therapy Modalities, Telerehabilitation

About this trial
This is an interventional treatment trial for COVID-19 focused on measuring COVID-19, Physical Therapy, Telerehabilitation, Primary Health Care
Eligibility Criteria
Inclusion Criteria:
- Patients with long post-COVID symptoms (from week 12 to week 24).
- Patients between 25 and 70 years old.
- Patients with moderate respiratory and/or functional affectation with long post covid-19 symptoms, belonging to four Physiotherapy Units of primary Health Care in Madrid (Spain).
- Confirmed diagnosis of COVID-19 via a positive nasopharyngeal or throat swab within the past 12 months.
- Persistent symptoms lasting ≥12 weeks since the first positive test, including dyspnea (new or increased from baseline as measured by modified Medical Research Council (mMRC) score ≥1).
- Normal oxygen saturation (greater than 90%) by pulse oximetry at rest on room air.
- Participant owns a smart phone, tablet, or computer to access on-line sessions.
Exclusion Criteria:
- People with symptoms such as fever, cough, upper respiratory distress, diarrhea, vomiting, anosmia or ageusia.
- Temperature greater than 37.2ºC.
- Patients with multimorbidity. Multimorbidity will be considered when the patient is diagnosed with two or more diseases among the following: diabetes, dyslipidaemia, cardiovascular disease (arterial hypertension, ischemic heart disease, valvular heart disease, heart failure), osteoarthritis, respiratory disease (asthma, chronic bronchitis), digestive disease ( gastric or duodenal ulcers, inflammatory bowel disease, liver disease), psychiatric pathology or tumor pathology.
- Patients with previous pathologies: ischemic heart disease, dementia, lung failure, lung cancer, cystic fibrosis, pulmonary fibrosis, chronic kidney failure, liver diseases, myocardial arrhythmias, deep vein thrombosis, severe aortic stenosis, liver diseases.
- Patients with weakened immune systems: in cancer treatment, organ or marrow transplant patients, HIV/AIDS, prolonged use of prednisone or similar medication.
- Patients with functional limitations to carry out their basic activities of daily living. Barthel index greater than 90.
- Patients with cognitive problems. Mini-Cognitive Lobo exam greater than 23 points
- Active bleeding.
- Unstable fractures.
Sites / Locations
- María José Díaz Arribas
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Tele-physiotherapy group
Control group
Allocated participants to intervention group will receive 18 Tele-physiotherapy sessions (three sessions per week, with 30 min. of duration) during six weeks. In this sessions, participants will carry out a tele-face-to-face multimodal physical therapy program based on health education, respiratory exercises, physical training exercises, aerobic exercises and functional mobility. This group will receive conventional medical care too.
No Physical therapy intervention. Allocated participants to control group will receive one consultation session by the physiotherapist, but will not received any physical Therapy treatment. At this session, patients will be educated about how to perform their daily activities, breathing exercises, walking. Conventional medical care will be provided. In the control group, the same measurements will be made at the same times as the subjects in the intervention group. Once the study is finished, the researcher agrees to carry out the intervention to the patients in the control group.